Concepedia

Erik Asmus

EA

7

Publications

660

Citations

7

H-Index

2016

Active since

Affiliations

WinnMed(Current)

Mayo Clinic in Florida

Mayo Clinic

Mayo Clinic in Arizona

Cornell University

Erik Asmus is an author at WinnMed specializing in clinical trials, radiation oncology, and immunotherapy.

Top concepts

Publications per year

2016–2022

7

Publications

7

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

Wei Ding, Betsy LaPlant, Timothy G. Call et al. · Blood · 2017 · 411 citations · Full text

Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers

Gerardo Colón‐Otero, Valentina Zanfagnin, Xiaonan Hou et al. · ESMO Open · 2020 · 85 citations · Full text

A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer

Ashish V. Chintakuntlawar, Jun Yin, Robert L. Foote et al. · Thyroid · 2019 · 77 citations

Fixed Duration Therapy with Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone for High Risk Smoldering Multiple Myeloma-Results of the Ascent Trial

Shaji Kumar, Melissa Alsina, Betsy LaPlant et al. · Blood · 2022 · 37 citations

, , +9

Clinical Significance of Circulating Tumor Cells in Hormone Receptor–positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab

Mark Jesus M. Magbanua, Oleksandr Savenkov, Erik Asmus et al. · Clinical Cancer Research · 2020 · 24 citations · Full text

Rows per page

1–5 of 7